The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Increased Plasma 21-Deoxycorticosterone (21-DB) Levels in Late-Onset Adrenal 21-Hydroxylase Deficiency Suggest a Mild Defect of the Mineralocorticoid Pathway
Abstract
Plasma 21-deoxycorticosterone (21-DB) concentrations were measured before (basal) and 1 h after ACTH stimulation in a population of 34 normal subjects, 18 patients with the late-onset form of congenital adrenal hyperplasia (LO-CAH) due to 21-hydroxylase deficiency, and 19 LOCAH heterozygotes. For comparison, plasma 21-deoxycortisol (21-DOF) and 17-hydroxyprogesterone (17-OHP) were determined simultaneously in the same subjects. Plasma 21-DB concentrations as well as those of 21-DOF did not vary significantly as a function of age, sex, or phase of the menstrual cycle, in contrast to plasma 17-OHP. The mean plasma 21-DB concentrations in normal subjects (adult men, follicular and luteal phase women, and children) were 19.0 +/- 9.5 (+/- SD) pmol/L before and 73.2 +/- 31.0 after ACTH stimulation. In the LOCAH patient group, the mean post-ACTH plasma 21-DB concentration was 1736.0 +/- 1243.0 pmol/L, and all values were above the highest post-ACTH value (148.2 pmol/L) in the normal subjects. Similarly, in the LOCAH patients the post-ACTH plasma 21-DOF concentration was 33.7 +/- 20.3 nmol/L, and the post-ACTH plasma 17-OHP value was 134.0 +/- 70.6 nmol/L; all LOCAH patients had supranormal responses to ACTH. However, 38.9%, 11.2% and 16.7% of the basal plasma 21-DB, 21-DOF, and 17-OHP values in the LOCAH patients overlapped those in the normal subjects. There was a rather large overlap (63.2%) in post-ACTH plasma 21-DB levels between the LOCAH heterozygotes and the normal subjects; it was less than the overlap in plasma 17-OHP (74%) and more than the overlap in plasma 21-DOF values (5.2%) in these same 2 groups. There was moderate overlap (21%) in the post-ACTH plasma 21-DB levels between the LOCAH heterozygotes and LOCAH patients, but no overlap between these 2 groups for either 21-DOF or 17-OHP. The abnormally elevated post-ACTH plasma 21-DB levels found in all the LOCAH patients as well as in some LOCAH heterozygotes suggest the existence of minor 21-hydroxylase deficiency in the mineralocorticoid synthetic pathway in these patients in addition to the well known impairment in the glucocorticoid pathway demonstrated by the elevated post-ACTH 21-DOF and 17-OHP levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, these individuals have hormonal evidence of mild mineralocorticoid deficiency, as predicted from the existence of a single adrenal 21-hydroxylase (418), and may have elevated plasma renin activity in response to sodium restriction.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [418]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
(2010) · Encyclopedia of Research Design · doi:10.4135/9781412961288.n273 · Cited by 1,414
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Chromatographic Separation of Steroid Hormones for Use in Radioimmunoassay
Abraham, G. E., Buster, J. E., Lucas, L. A., Corrales, P. C., & Teller, R. C. (1972) · Analytical Letters · doi:10.1080/00032717208062116 · Cited by 214
Late-onset adrenal hyperplasia in hirsutism
Kuttenn, F., Couillin, P., Girard, F., Billaud, L., Vincens, M., Boucekkine, C., Thalabard, J.-C., Maudelonde, T., Spritzer, P., Mowszowicz, I., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130404 · Cited by 213
Self-citationAn Attenuated Form of Congenital Virilizing Adrenal Hyperplasia*
Rosenwaks, Z., Lee, P. A., Jones, G. S., Migeon, C. J., & Wentz, A. C. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-3-335 · Cited by 102
FIET, J., GUEUX, B., GOURMELEN, M., KUTTENN, F., VEXIAU, P., COUILLIN, P., PHAM-HUU-TRUNG, M.-T., VILLETTE, J.-M., RAUX-DEMAY, M., GALONS, H., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-659 · Cited by 90
Self-citationInborn errors of steroid biosynthesis.
Finkelstein, M., & SHAEFER, J. M. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.2.353 · Cited by 88
Milewicz, A., Vecsei, P., KORTH-SCHÜTZ, S., Haack, D., Rösler, A., LICHTWALD, K., Lewicka, S., & von Mittelstaedt, G. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90382-0 · Cited by 57
LORENZEN, F., PANG, S., New, M. I., Pollack, M. S., Oberfield, S. E., Dupont, B., CHOW, D. M., Schneider, B., & Levine, L. S. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-3-572 · Cited by 54
Plasma 17-Hydroxyprogesterone, 21-Deoxycortisol and Cortisol in Congenital Adrenal Hyperplasia*
FRANKS, R. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-6-1099 · Cited by 53
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.
Chiou, S. H., Hu, M. C., & Chung, B. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39804-7 · Cited by 149
Metadata
- Authors
- FIET, J., GUEUX, B., RAUXDEMAY, M.-C., KUTTENN, F., VEXIAU, P., BRERAULT, J., COUILLIN, P., GALONS, H., VILLETTE, J., JULIEN, R., & DREUX, C.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1989-03
- Volume
- 68
- Issue
- 3
- Pages
- 542-547
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2073459673
- Cited by
- 40
- References
- 24
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2015: 1 · 2012: 1
- FWCI
- 0.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- late-onset congenital adrenal hyperplasia, 21-hydroxylase deficiency, 21-deoxycortisol, 17-hydroxyprogesterone, ACTH stimulation test, heterozygotes, plasma steroid levels, ACTH response, menstrual cycle variation
- MeSH terms
- Adrenal Glands, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Adult, Child, Cortodoxone, Desoxycorticosterone, Female, Heterozygote, Humans, Hydroxyprogesterones, Male, Middle Aged, Steroid Hydroxylases, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Plasma 21-Deoxycorticosterone (21-DB) Levels in Late-Onset Adrenal 21-Hydroxylase Deficiency Suggest a Mild Defect of the Mineralocorticoid Pathway. https://app.cochat.ai/papers/10.1210/jcem-68-3-542
- The paper
- FIET, J., GUEUX, B., RAUXDEMAY, M.-C., KUTTENN, F., VEXIAU, P., BRERAULT, J., COUILLIN, P., GALONS, H., VILLETTE, J., JULIEN, R., & DREUX, C. (1989). Increased Plasma 21-Deoxycorticosterone (21-DB) Levels in Late-Onset Adrenal 21-Hydroxylase Deficiency Suggest a Mild Defect of the Mineralocorticoid Pathway. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-68-3-542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.